These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 1827688

  • 1. Arginine-specific suppression of mixed lymphocyte culture reactivity by Kupffer cells--a basis of portal venous tolerance.
    Callery MP, Mangino MJ, Flye MW.
    Transplantation; 1991 May; 51(5):1076-80. PubMed ID: 1827688
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A biologic basis for limited Kupffer cell reactivity to portal-derived endotoxin.
    Callery MP, Mangino MJ, Flye MW.
    Surgery; 1991 Aug; 110(2):221-30. PubMed ID: 1858031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium.
    Roland CR, Mangino MJ, Duffy BF, Flye MW.
    Transplantation; 1993 May; 55(5):1151-8. PubMed ID: 8388586
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production.
    Goss JA, Mangino MJ, Flye MW.
    Ann Surg; 1992 Jun; 215(6):553-9; discussion 559-60. PubMed ID: 1632677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kupffer cell autoregulation of IL-1 production by PGE2 during hepatic regeneration.
    Goss JA, Mangino MJ, Flye MW.
    J Surg Res; 1992 May; 52(5):422-8. PubMed ID: 1619908
    [Abstract] [Full Text] [Related]

  • 9. Portal venous transfusion up-regulates Kupffer cell cyclooxygenase activity: a mechanism of immunosuppression in organ transplantation.
    Perez RV, Swanson C, Morgan M, Erickson K, Hubbard NE, German JB.
    Transplantation; 1997 Jul 15; 64(1):135-9. PubMed ID: 9233713
    [Abstract] [Full Text] [Related]

  • 10. Selective targeting of Kupffer cells with liposomal butyrate augments portal venous transfusion-induced immunosuppression.
    Perez RV, Johnson J, Hubbard NE, Erickson K, Morgan M, Kim S, Rudich SM, Katznelson S, German JB.
    Transplantation; 1998 May 27; 65(10):1294-8. PubMed ID: 9625008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lanthanide "blockade" of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis.
    Roland CR, Mangino MJ, Flye MW.
    J Surg Res; 1993 May 27; 54(5):401-10. PubMed ID: 8361165
    [Abstract] [Full Text] [Related]

  • 14. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation.
    Kamei T, Callery MP, Flye MW.
    J Surg Res; 1990 May 27; 48(5):393-6. PubMed ID: 2352416
    [Abstract] [Full Text] [Related]

  • 15. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S, Nakafusa Y, Flye MW.
    Surgery; 1994 Aug 27; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [Abstract] [Full Text] [Related]

  • 16. Kupffer cell-mediated lymphocyte apoptosis: a PGE2-dependent mechanism of portal venous transfusion-induced immunosuppression?
    Perez R, Johnson J, Winkler JD, Rudich S, Carter L, Katznelson S, German JB.
    J Surg Res; 1998 Jul 15; 78(1):37-41. PubMed ID: 9733615
    [Abstract] [Full Text] [Related]

  • 17. Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function.
    Perez R, Stevenson F, Johnson J, Morgan M, Erickson K, Hubbard NE, Morand L, Rudich S, Katznelson S, German JB.
    J Surg Res; 1998 Jul 15; 78(1):1-6. PubMed ID: 9733608
    [Abstract] [Full Text] [Related]

  • 18. Suppression of polyclonal, tumor cell and alloantigen-induced proliferation: identification of cyclooxygenase pathway dependent and independent mechanisms.
    Hogan KT, Hollingsworth MA, Seymour RE, Quinn MK, Evans DL.
    Immunopharmacology; 1984 Feb 15; 7(1):49-57. PubMed ID: 6232242
    [Abstract] [Full Text] [Related]

  • 19. Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-alpha, transforming growth factor-beta, and nitric oxide.
    Roland CR, Goss JA, Mangino MJ, Hafenrichter D, Flye MW.
    Ann Surg; 1994 Apr 15; 219(4):389-99. PubMed ID: 8161265
    [Abstract] [Full Text] [Related]

  • 20. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine.
    Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL.
    J Immunol; 1990 Oct 01; 145(7):2220-6. PubMed ID: 2144548
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.